Abstract
The chiral opioid analgesic tramadol was patented (1962) as a cis- and trans-racemates mixture. A first chiral switch led to the (±)-cis-(1RS,2RS) racemate, patented and approved as Tramal (1980), preferred over the (+)-cis-(1R,2R)-enantiomer. Consecutive chiral switches of (±)-cis-tramadol to (+)-cis-(1R,2R)-tramadol/salts were patented. This Viewpoint calls for developing (+)-cis-(1R,2R)-tramadol medicines and recognizing tramadol medicines as potential psychedelics to overcome the spreading tramadol crisis.
Original language | English |
---|---|
Pages (from-to) | 1409-1416 |
Number of pages | 8 |
Journal | ACS Medicinal Chemistry Letters |
Volume | 15 |
Issue number | 9 |
DOIs | |
State | Published - 12 Sep 2024 |
Bibliographical note
Publisher Copyright:© 2024 American Chemical Society.
Keywords
- Analgesics
- Chiral Switch
- Opioid Crisis
- Patents
- Psychedelic
- Stereochemistry
- Tramadol